Journal article icon

Journal article

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.

Abstract:

BACKGROUND: The recent introduction of the depot somatostatin analogues octreotide LAR and lanreotide represent major advances in the medical treatment of acromegaly. However, it is uncertain whether the recommended dose intervals of 4 weeks and 10-14 days, respectively, are applicable to all patients. AIMS: To determine the optimum intervals between depot injections of either octreotide LAR and lanreotide for the suppression of serum GH and IGF-I in patients with acromegaly. Twenty-seven pat...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Clinical endocrinology
Volume:
53
Issue:
6
Pages:
719-724
Publication date:
2000-12-01
DOI:
EISSN:
1365-2265
ISSN:
0300-0664
Source identifiers:
138333
Language:
English
Keywords:
Pubs id:
pubs:138333
UUID:
uuid:4672ee54-cc67-4cdd-8e8a-b00ec3aea981
Local pid:
pubs:138333
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP